CD24 and breast carcinoma: A pioneering study has indicated that CD24 is a significant marker linked to tumor metastasis, increased cell proliferation, motility, and invasiveness of abnormal fat accumulation in the body, and is associated with poor clinical outcomes in breast carcinomas [60].